In 2018, the cancer drug larotrectinib quietly became a milestone along the evolving path to approaching cancer therapy: it was the first agent approved to treat a genetic variant, not a specific type of cancer or disease site. And as oncology treatment science progresses, many predict that it won’t be the last—it’s already been joined by pembrolizumab and entrectinib as tumor-agnostic therapies. The key to curing cancer may be hidden in the disease’s genetic code rather than its location in the body.
With the aging population of clinicians and patients, nursing is in desperate need of a stronger workforce. To advance nurses at all levels of practice, on February 9, 2021, the U.S. House Committee on Energy and Commerce announced its plan to increase funding for the Nurse Corps Loan Repayment Program by $200 million through its section of the American Rescue Plan.
I believe that every nurse is a leader, and we need leaders in all areas of our profession, from academia and research to clinical practice. Nurses must lead from the future and reinvent themselves to achieve their desired career path. Practice in the now, but lead from anticipation of what will happen based on healthcare trends.
To address complex trauma resulting from the COVID-19 coronavirus pandemic, ONS collaborated with four leading organizations to develop and offer free innovative and educational resources about grief for frontline providers. Joining ONS in the endeavor are the Hospice and Palliative Nurses Foundation (HPNF), Hospice and Palliative Nurses Association (HPNA), Social Work Hospice and Palliative Care Network (SWHPN), and Association of Professional Chaplains (APC).
BRCA1- or BRCA2-associated hereditary breast and ovarian cancer is the most common form of hereditary breast and ovarian cancer. The prevalence of BRCA1 and BRCA2 pathogenic variants in the general population is estimated at 1 in 400–500 people, although it increases to 1 in 40 for those of Ashkenazi Jewish ancestry, which is linked to three founder pathogenic variants (BRCA1 c.68_69delAG, BRCA1c.5266dupC, and BRCA2 c.5946delT).
On May 5, 2021, the U.S. Food and Drug Administration (FDA) granted accelerated approval to pembrolizumab (Keytruda®) in combination with trastuzumab and fluoropyrimidine- and platinum-containing chemotherapy for first-line treatment of patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma.
The Decipher genomics test, which measures activity of 22 genes among seven known cancer pathways, independently estimates patients’ risk of prostate cancer metastasis, death, and overall survival and helps identify patients most likely to benefit from hormone therapy, researchers reported in study findings published in JAMA Oncology.
When you picture a nurse leader, what do you see? The thought of being a leader or taking on a formal leadership role can seem intimidating for so many nurses. But age, citizenship status, ethnicity, or gender are strengths, not obstacles. Every nurse enters the profession with the foundation to be a successful leader.
May is the month we celebrate nursing across the world. May 12, Florence Nightingale’s birthday, is International Nurses Day, designated as such since 1974 by the International Council of Nurses. This year’s theme is Nurses: A Voice to Lead, A Vision for Future Health Care in recognition of nursing's role on the front lines of the pandemic.
Last year, I was involved in the care of Emma (not her real name), a 22-year-old woman with duodenal adenocarcinoma. Cancers of the small intestine are very rare, accounting for less than 1% of all cancers diagnosed in a given year. Because the average age at diagnosis is 66 years, Emma was unusual to have been diagnosed at only 20. But Emma was an exceptional patient in many ways beyond her rare diagnosis: she was remarkably resilient for one so young and came armed with an incredible support system of loved ones.